Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial

Background and objectives: Aseprugo procumbens is used as antianxety and depression in Iranian traditional medicine; however no clinical trial has been performed about these properties. The aim of this study was to evaluate the antidepressant efficacy and safety of hydroalcoholic extract of A. procu...

Full description

Bibliographic Details
Main Authors: Mehran Zarghami, Aroona Chabra, Mohammad Azadbakht*, Alireza Khalilian, Ali Asghar Hoseini
Format: Article
Language:English
Published: Iranian Society of Pharmacognosy 2018-06-01
Series:Research Journal of Pharmacognosy
Subjects:
Online Access:http://www.rjpharmacognosy.ir/article_64860_3f60b43d8238c9a451f59d5fa6d87dd9.pdf
_version_ 1818928155248820224
author Mehran Zarghami
Aroona Chabra
Mohammad Azadbakht*
Alireza Khalilian
Ali Asghar Hoseini
author_facet Mehran Zarghami
Aroona Chabra
Mohammad Azadbakht*
Alireza Khalilian
Ali Asghar Hoseini
author_sort Mehran Zarghami
collection DOAJ
description Background and objectives: Aseprugo procumbens is used as antianxety and depression in Iranian traditional medicine; however no clinical trial has been performed about these properties. The aim of this study was to evaluate the antidepressant efficacy and safety of hydroalcoholic extract of A. procumbens. Methods: In this double blind study, 30 outpatients with mild to moderate depressive disorder (according to DMS-IV-TR criteria who had a score of 18-25 on the Hamilton Depression Rating Scale (HDRS) were randomly divided in two group, 1) received 10 mg fluoxetine capsule, 2) received 1.2 g dried extract of A. procumbens capsule (6 mg flavonoid,) orally per day. Patients were followed up for 6 weeks; the recovery process was assessed by the HDRS in weeks 0, 2, 4 and 6. Results: A significant decrease in HDRS was observed in both groups after the fourth week. After the sixth week, fluoxetine had a greater anti-depressant activity than A. procumbens (p value =0.03). There were no significant differences in terms of adverse effects in both groups. Conclusions: The hydroalcoholic extract of A. procumbens can be considered as an effective and safe remedy for mild to moderate depressive disorder.
first_indexed 2024-12-20T03:24:25Z
format Article
id doaj.art-507c0663638f43829ed0da88f50edfcd
institution Directory Open Access Journal
issn 2345-4458
2345-5977
language English
last_indexed 2024-12-20T03:24:25Z
publishDate 2018-06-01
publisher Iranian Society of Pharmacognosy
record_format Article
series Research Journal of Pharmacognosy
spelling doaj.art-507c0663638f43829ed0da88f50edfcd2022-12-21T19:55:07ZengIranian Society of PharmacognosyResearch Journal of Pharmacognosy2345-44582345-59772018-06-0153152010.22127/rjp.2018.6486064860Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical TrialMehran Zarghami0Aroona Chabra1Mohammad Azadbakht*2Alireza Khalilian3Ali Asghar Hoseini4Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.Department of Pharmacognosy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.Department of Pharmacognosy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.Department of Biostatistics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.Department of Psychiatry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.Background and objectives: Aseprugo procumbens is used as antianxety and depression in Iranian traditional medicine; however no clinical trial has been performed about these properties. The aim of this study was to evaluate the antidepressant efficacy and safety of hydroalcoholic extract of A. procumbens. Methods: In this double blind study, 30 outpatients with mild to moderate depressive disorder (according to DMS-IV-TR criteria who had a score of 18-25 on the Hamilton Depression Rating Scale (HDRS) were randomly divided in two group, 1) received 10 mg fluoxetine capsule, 2) received 1.2 g dried extract of A. procumbens capsule (6 mg flavonoid,) orally per day. Patients were followed up for 6 weeks; the recovery process was assessed by the HDRS in weeks 0, 2, 4 and 6. Results: A significant decrease in HDRS was observed in both groups after the fourth week. After the sixth week, fluoxetine had a greater anti-depressant activity than A. procumbens (p value =0.03). There were no significant differences in terms of adverse effects in both groups. Conclusions: The hydroalcoholic extract of A. procumbens can be considered as an effective and safe remedy for mild to moderate depressive disorder.http://www.rjpharmacognosy.ir/article_64860_3f60b43d8238c9a451f59d5fa6d87dd9.pdfAsperugo procumbensbadranjbuyehDepressionfluoxetine
spellingShingle Mehran Zarghami
Aroona Chabra
Mohammad Azadbakht*
Alireza Khalilian
Ali Asghar Hoseini
Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
Research Journal of Pharmacognosy
Asperugo procumbens
badranjbuyeh
Depression
fluoxetine
title Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
title_full Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
title_fullStr Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
title_full_unstemmed Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
title_short Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
title_sort antidepressant effect of asperugo procumbens l in comparison with fluoxetine a randomized double blind clinical trial
topic Asperugo procumbens
badranjbuyeh
Depression
fluoxetine
url http://www.rjpharmacognosy.ir/article_64860_3f60b43d8238c9a451f59d5fa6d87dd9.pdf
work_keys_str_mv AT mehranzarghami antidepressanteffectofasperugoprocumbenslincomparisonwithfluoxetinearandomizeddoubleblindclinicaltrial
AT aroonachabra antidepressanteffectofasperugoprocumbenslincomparisonwithfluoxetinearandomizeddoubleblindclinicaltrial
AT mohammadazadbakht antidepressanteffectofasperugoprocumbenslincomparisonwithfluoxetinearandomizeddoubleblindclinicaltrial
AT alirezakhalilian antidepressanteffectofasperugoprocumbenslincomparisonwithfluoxetinearandomizeddoubleblindclinicaltrial
AT aliasgharhoseini antidepressanteffectofasperugoprocumbenslincomparisonwithfluoxetinearandomizeddoubleblindclinicaltrial